China can help_老虎社区_美港股上老虎

2021-06-09

China can help

Problems at biggest vaccine maker in India leave world short on Covid-19 shots

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":180584679,"tweetId":"180584679","gmtCreate":1623212639491,"gmtModify":1631884666605,"author":{"id":3581711420498497,"idStr":"3581711420498497","authorId":3581711420498497,"authorIdStr":"3581711420498497","name":"Jomum","avatar":"https://static.tigerbbs.com/4f76fac17668e3f2183dc6576449da0a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>China can help</p></body></html>","htmlText":"<html><head></head><body><p>China can help</p></body></html>","text":"China can help","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/180584679","repostId":2142299762,"repostType":4,"repost":{"id":"2142299762","kind":"news","pubTimestamp":1623207147,"share":"https://www.laohu8.com/m/news/2142299762?lang=&edition=full","pubTime":"2021-06-09 10:52","market":"sg","language":"en","title":"Problems at biggest vaccine maker in India leave world short on Covid-19 shots","url":"https://stock-news.laohu8.com/highlight/detail?id=2142299762","media":"The Straits Times","summary":"NEW DELHI (BLOOMBERG) - Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots ha","content":"<div>\n<p>NEW DELHI (BLOOMBERG) - Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programs as they run out of doses. Many of those...</p>\n\n<a href=\"http://www.straitstimes.com/asia/south-asia/problems-at-biggest-vaccine-maker-in-india-leave-world-short-on-covid-19-shots\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Problems at biggest vaccine maker in India leave world short on Covid-19 shots</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProblems at biggest vaccine maker in India leave world short on Covid-19 shots\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-09 10:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/asia/south-asia/problems-at-biggest-vaccine-maker-in-india-leave-world-short-on-covid-19-shots><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW DELHI (BLOOMBERG) - Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programs as they run out of doses. Many of those...</p>\n\n<a href=\"http://www.straitstimes.com/asia/south-asia/problems-at-biggest-vaccine-maker-in-india-leave-world-short-on-covid-19-shots\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","PFE":"辉瑞","AZN":"阿斯利康"},"source_url":"http://www.straitstimes.com/asia/south-asia/problems-at-biggest-vaccine-maker-in-india-leave-world-short-on-covid-19-shots","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142299762","content_text":"NEW DELHI (BLOOMBERG) - Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programs as they run out of doses. Many of those shortages can be traced back to a single company: The Serum Institute of India.The world's largest vaccine maker, Serum was last year named a top supplier of Covid shots to Covax, the World Health Organization-backed initiative aimed at securing an equitable global rollout. But the Indian company has been dogged by setbacks, from a ban on exports to a factory fire, that have hampered its ability to fill orders.Covax has pledged to send shots to some 92 countries, but has so far received only 30 million of the minimum 200 million doses it ordered from Serum, which was to provide the bulk of its early supply.Serum's travails have now become a key illustration of how the effort to inoculate against Covid has failed the developing world, and a cautionary tale for becoming over-reliant on one manufacturer amid a global crisis.The shortages come as the WHO and public health experts warn that low levels of vaccination in poorer nations could fuel the emergence of dangerous variants and lengthen the global pandemic.Other manufacturers have also had trouble meeting targets or ramping up production of Covid shots, yet Serum's shortfalls are particularly consequential because Covax and emerging countries were counting on it so heavily.The company has been unable to send any shots overseas since April, when the Indian government banned Covid vaccine exports amid the country's devastating second wave. But some of Serum's problems began long before.Last year, Serum's chief executive officer, Adar Poonawalla, pledged that his vaccine producing colossus would churn out 400 million doses of AstraZeneca Plc's coronavirus shot for low and middle-income countries by the end of 2020.A month into 2021, he said it had manufactured only 70 million shots because the company had been uncertain about when it would receive a license from India and didn't have enough warehouse space.A string of nations had also entered into direct contracts with Serum and are now racing to find new suppliers.In Nepal - which is struggling with a severe outbreak that's even reached base camp of Mount Everest - the government says it's received only half of the 2 million shots it ordered directly from Serum, based in the city of Pune in neighbouring India. The rest were supposed to arrive by March.\"We are struggling with the shortage of vaccines,\" said Tara Nath Pokhrel, the director of the family welfare division at Nepal's health ministry.In total, the nation of 28 million people says it's received only 2.38 million doses: 1 million directly from Serum, another 1 million in grant aid from India, and the rest from Covax.","news_type":1},"isVote":1,"tweetType":1,"viewCount":231,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["CAAS"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":12,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/180584679"}